第一医药（600833）8月25日主力资金净流入2477.42万元

Core Insights - First Pharmaceutical (600833) reported a closing price of 13.51 yuan as of August 25, 2025, with a 2.82% increase and a turnover rate of 5.63% [1] - The company experienced a net inflow of main funds amounting to 24.77 million yuan, representing 14.82% of the total transaction amount [1] Financial Performance - Total operating revenue for the first half of 2025 reached 999.7 million yuan, reflecting an 11.58% year-on-year growth [1] - Net profit attributable to shareholders was 14.02 million yuan, a significant decrease of 89.19% year-on-year [1] - Deducting non-recurring gains and losses, the net profit was 9.01 million yuan, showing a 24.58% year-on-year increase [1] - Current ratio stood at 1.587, quick ratio at 1.003, and debt-to-asset ratio at 44.51% [1] Company Overview - Shanghai First Pharmaceutical Co., Ltd. was established in 1992 and is primarily engaged in retail [2] - The company has a registered capital of 2.23086347 billion yuan and a paid-in capital of 980.21194 million yuan [1] - The legal representative of the company is Zhang Haibo [1] Investment and Intellectual Property - The company has made investments in 20 enterprises and participated in 16 bidding projects [2] - It holds 38 trademark registrations and 1 patent, along with 25 administrative licenses [2]